Treatment of hematology patients with high-risk fever of unknown origin during neutropenia
In this MEDtalk, Nick De Jonge, a Hematologist working at the Amsterdam University Medical center, presents the main result of a landmark study published in Lancet Haematology. The study aims to improve antibiotic treatment for hematology patients presenting with fever.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
